ES
58
-2
FITB
50
-5
IPG
36
-4
BLK
58
-3
ORLY
60
-5
EA
30
-6
VRSN
53
-2
FSLR
52
-6
JPM
55
-5
HBAN
45
-3
EQT
40
-16
QRVO
29
-18
PCG
78
-7
COST
48
-6
RRC
39
-3
CSX
37
-6
CTAS
52
-7
PEG
62
-7
NRG
44
-8
VMC
42
-2
ES
58
-2
FITB
50
-5
IPG
36
-4
BLK
58
-3
ORLY
60
-5
EA
30
-6
VRSN
53
-2
FSLR
52
-6
JPM
55
-5
HBAN
45
-3
EQT
40
-16
QRVO
29
-18
PCG
78
-7
COST
48
-6
RRC
39
-3
CSX
37
-6
CTAS
52
-7
PEG
62
-7
NRG
44
-8
VMC
42
-2
Financhill
Back

Cytokinetics Stock Predictions

#1 free indicator forecasts the next market drop here

Discover my #1 trading indicator here.
Sell
49

CYTK
Cytokinetics

Last Price:
54.16
Seasonality Move:
-7.4%

7 Day Trial

ALL ACCESS PASS

$ 7

The Biggest Financial Event of 2024?

Click here to find out.

Cytokinetics Stock Forecast

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.1% based on the past 20 years of stock performance.
  • Cytokinetics has risen higher in 10 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Cytokinetics Stock Undervalued?
    The current Cytokinetics [CYTK] share price is $54.11. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cytokinetics Stock Go Up Next Year?

  • Over the next 52 weeks, Cytokinetics has on average historically risen by 10.1% based on the past 20 years of stock performance.

Cytokinetics Stock Rating

Sell
49
Cytokinetics (CYTK) is a Sell

Is Cytokinetics overpriced?

  • Cytokinetics has risen higher in 10 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Cytokinetics Stock Price History

Is CYTK stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com

52-Week Data

52-Week High:
110.25
52-Week Low:
25.98

Prediction Charts

Market Cap:
6.37B
Price in USD:
54.11
Volume:
1.21M
Beta:
1.45

Technical Analysis

SMA50:
56.16
SMA100:
57.10
SMA200:
61.77
52-Wk Change:
51.1%

Stock Predictions

  • Is Cytokinetics stock public?
    Yes, Cytokinetics is a publicly traded company.
  • What is the Cytokinetics stock quote today?
    The Cytokinetics stock price is 54.11 USD today.
  • How to buy Cytokinetics stock online?
    You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-19 56.56 56.46 57.38 55.63
Aug-20 56.37 56.85 57.23 55.58
Aug-21 57.00 56.58 58.21 56.22
Aug-22 56.83 56.28 56.91 55.43
Aug-23 56.57 57.32 57.94 56.21
Aug-26 57.56 57.07 58.05 56.85
Aug-27 56.73 55.85 57.22 55.32
Aug-28 55.43 55.53 55.92 55.02
Aug-29 55.99 57.39 58.68 55.21
Aug-30 57.94 57.03 57.98 56.28
Sep-3 56.72 54.51 57.80 54.22
Sep-4 54.29 54.89 55.05 53.16
Sep-5 55.50 55.98 56.87 54.68
Sep-6 56.19 54.11 56.36 53.21

Cytokinetics Earnings

Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytokinetics Forecast Revenue Growth

Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.28 per share, and an increase next year of $0.29 per share.

* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.